SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aperture Associates LP et al, et al. – ‘SC 13G/A’ on 2/17/98 re: Oncogenex Pharmaceuticals, Inc.

As of:  Tuesday, 2/17/98   ·   Accession #:  901309-98-16   ·   File #:  5-45969

Previous ‘SC 13G’:  ‘SC 13G/A’ on 2/14/97   ·   Next:  ‘SC 13G’ on 2/2/00   ·   Latest:  ‘SC 13G/A’ on 2/13/01

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/17/98  Aperture Associates LP et al      SC 13G/A               2:21K  Oncogenex Pharmaceuticals, Inc.   Nixon Peabody LLP/FA
          Aperture Associates LP et al
          Aperture Associates, L.P.
          Aperture Partners, L.P.
          Gary L. Bridge
          Horsley Bridge Partners, Inc.
          Kevin P. Wright
          N. Dan Reeve
          S. Phillip Horsley

Amendment to Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Amendment to Statement of Beneficial Ownership        14     42K 
 2: EX-99       Miscellaneous Exhibit                                  1      7K 


SC 13G/A   —   Amendment to Statement of Beneficial Ownership
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
10Item 4. Ownership
12Item 5. Ownership of Five Percent or Less of A Class
"Item 6. Ownership of More Than Five Percent on Behalf of Another Person
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
13Item 8. Identification and Classification of Members of the Group
"Item 9. Notice of Dissolution of Group
"Item 10. Certification
SC 13G/A1st Page of 14TOCTopPreviousNextBottomJust 1st
 

Page 1 of 15 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SONUS PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 835692104 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SC 13G/A2nd Page of 14TOC1stPreviousNextBottomJust 2nd
CUSIP No. 835692104 Page 2 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aperture Associates, L.P. 94-3128732 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------- (5) SOLE VOTING POWER 448,334 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 448,334 ----------------------------------- (8) SHARED DISPOSITIVE POWER 0 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 448,334 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.2% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* PN ---------------------------------------------------------------
SC 13G/A3rd Page of 14TOC1stPreviousNextBottomJust 3rd
CUSIP No. 835692104 Page 3 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Horsley Bridge Partners, Inc. 16-1193261 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 697,759 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 697,759 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 697,759 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.1% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IA, CO ---------------------------------------------------------------
SC 13G/A4th Page of 14TOC1stPreviousNextBottomJust 4th
CUSIP No. 835692104 Page 4 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Kevin P. Wright 119-32-6933 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 0 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IN ---------------------------------------------------------------
SC 13G/A5th Page of 14TOC1stPreviousNextBottomJust 5th
CUSIP No. 835692104 Page 5 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aperture Partners, L.P. 94-3128731 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 448,334 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 448,334 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 448,334 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.2% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* PN ---------------------------------------------------------------
SC 13G/A6th Page of 14TOC1stPreviousNextBottomJust 6th
CUSIP No. 835692104 Page 6 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON S. Phillip Horsley 529-44-9975 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 697,759 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 697,759 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 697,759 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.1% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IN ---------------------------------------------------------------
SC 13G/A7th Page of 14TOC1stPreviousNextBottomJust 7th
CUSIP No. 835692104 Page 7 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Gary L. Bridge 529-50-1090 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 697,759 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 697,759 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 697,759 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.1% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IN ---------------------------------------------------------------
SC 13G/A8th Page of 14TOC1stPreviousNextBottomJust 8th
CUSIP No. 835692104 Page 8 of 15 pages --------------------------------------------------------------- (1) NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON N. Dan Reeve 489-54-0327 ---------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Instructions) (a) / / (b) /x/ --------------------------------------------------------------- (3) SEC USE ONLY --------------------------------------------------------------- (4) CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. --------------------------------------------------------------- (5) SOLE VOTING POWER 0 ----------------------------------- NUMBER OF SHARES (6) SHARED VOTING POWER BENEFICIALLY OWNED BY 448,334 EACH REPORTING PERSON----------------------------------- WITH (7) SOLE DISPOSITIVE POWER 0 ----------------------------------- (8) SHARED DISPOSITIVE POWER 448,334 --------------------------------------------------------------- (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 448,334 --------------------------------------------------------------- (10) CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / --------------------------------------------------------------- (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.2% --------------------------------------------------------------- (12) TYPE OF REPORTING PERSON* IN ---------------------------------------------------------------
SC 13G/A9th Page of 14TOC1stPreviousNextBottomJust 9th
Page 9 of 15 Pages ITEM 1. (a) NAME OF ISSUER. Sonus Pharmaceuticals, Inc. (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES. 22026 20th Avenue Southeast Suite 102 Bothell, Washington 98021 ITEM 2. (a) NAME OF PERSON FILING. Pursuant to Rule 13d-1(f)(1) of Regulation 13D-G of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the "Act"), the undersigned hereby file this Schedule 13G Amendment No. 2 on behalf of Aperture Associates, L.P. ("Aperture"), Horsley Bridge Partners, Inc. ("HBP"), Kevin P. Wright ("Wright"), Aperture Partners, L.P. ("Aperture Partners"), S. Phillip Horsley ("Horsley"), Gary L. Bridge ("Bridge") and N. Dan Reeve ("Reeve"). Aperture, HBP, Wright, Aperture Partners, Horsley, Bridge and Reeve are sometimes hereinafter collectively referred to as the "Reporting Persons." (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE. The principal business office of Aperture, HBP, Aperture Partners, Horsley, Bridge and Reeve is: 505 Montgomery Street San Francisco, California 94111 The residence of Wright is: 93 Langpap Road Honeoye Falls, New York 14472 (c) CITIZENSHIP. Each of Aperture, HBP and Aperture Partners is organized in the State of Delaware. Each of Wright, Horsley, Bridge and Reeve is a citizen of the U.S.A.
SC 13G/A10th Page of 14TOC1stPreviousNextBottomJust 10th
Page 10 of 15 Pages (d) TITLE OF CLASS OF SECURITY. Common Stock (e) CUSIP NUMBER. 835692104 ITEM 3. Not applicable. ITEM 4. OWNERSHIP. With respect to Aperture: (a) Amount Beneficially Owned: 448,334 (b) Percent of Class: 5.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 448,334 (ii) shared power to vote or to direct the vote: None (iii) sole power to dispose or to direct the disposition of: 448,334 (iv) shared power to dispose or to direct the disposition of: None With respect to Aperture Partners and Reeve: (a) Amount Beneficially Owned: 448,334 (b) Percent of Class: 5.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: None (ii) shared power to vote or to direct the vote: 448,334
SC 13G/A11th Page of 14TOC1stPreviousNextBottomJust 11th
Page 11 of 15 Pages (iii) sole power to dispose or to direct the disposition of: None (iv) shared power to dispose or to direct the disposition of: 448,334 With respect to Wright: (a) Amount Beneficially Owned: 0 (b) Percent of Class: 0.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: None (ii) shared power to vote or to direct the vote: None (iii) sole power to dispose or to direct the disposition of: None (iv) shared power to dispose or to direct the disposition of: None With respect to HBP, Horsley and Bridge: (a) Amount Beneficially Owned: 697,759 (b) Percent of Class: 8.1% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: None (ii) shared power to vote or to direct the vote: 697,759 (iii) sole power to dispose or to direct the disposition of: None (iv) shared power to dispose or to direct the disposition of: 697,759
SC 13G/A12th Page of 14TOC1stPreviousNextBottomJust 12th
Page 12 of 15 This statement relates to shares of Common Stock and warrants of the Issuer which are held by Aperture, Horsley Bridge Fund I, L.P., a New York limited partnership ("HB Fund I"), Horsley Bridge Fund II, L.P., a Delaware limited partnership ("HB Fund II"), Horsley Bridge Fund III, L.P., a Delaware limited partnership ("HB Fund III"), and the John Deere Pension Trust ("Deere"). The power to vote or to direct the vote and to dispose or to direct the disposition of Common Stock held by Aperture is exercised by the general partners of Aperture through a Management Committee comprised of Horsley, Bridge and Reeve. The power to vote or to direct the vote and to dispose or to direct the disposition of Common Stock held by HB Fund I, HB Fund II, HB Fund III and Deere is vested in HBP pursuant to a combination of management and partnership agreements. Horsley and Bridge, the trustees of certain family trusts which own all of the stock of HBP and are the directors of HBP, may be deemed to share the voting and dispositive power held by HBP. Mr. Horsley and Mr. Bridge also may be deemed to share voting and dispositive power because of their status as general partners of other partnerships which serve as general partners of Aperture, HB Fund I, HB Fund II and HB Fund III. Pursuant to Rule 13d-4 of Regulation 13D-G of the General Rules and Regulations under the Act: Aperture Partners, Horsley, Bridge and Reeve each disclaim beneficial ownership of the Common Stock of the Issuer owned by Aperture; Horsley and Bridge each disclaim beneficial ownership of the Common Stock of the Issuer owned by HB Fund I, HB Fund II, HB Fund III and Deere; and the filing of this Statement by such Reporting Persons shall not be construed as an admission that such Reporting Persons are, for the purposes of Section 13(d) or 13(g) of the Act, beneficial owners of such Common Stock. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Mr. Wright no longer has the shared power to vote or to direct the vote or to dispose or to direct the disposition of Common Stock held by Aperture and no longer is the beneficial owner of 5% of such Common Stock. This Section is not applicable with respect to the other Reporting Persons. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable.
SC 13G/A13th Page of 14TOC1stPreviousNextBottomJust 13th
Page 13 of 15 ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. Not applicable. [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
SC 13G/ALast Page of 14TOC1stPreviousNextBottomJust 14th
Page 14 of 15 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 17, 1998 APERTURE ASSOCIATES, L.P. By: Horsley Bridge Partners, Inc. Its: General Partner By: /s/ Phillip Horsley ------------------------ Phillip Horsley Its: President HORSLEY BRIDGE PARTNERS, INC. By: /s/ Phillip Horsley ------------------------------ Phillip Horsley Its: President /s/ Kevin P. Wright ------------------------------ KEVIN P. WRIGHT APERTURE PARTNERS, L.P. By: /s/ Phillip Horsley ------------------------------ Phillip Horsley Its: General Partner /s/ Phillip Horsley ------------------------------ PHILLIP HORSLEY /s/ Gary L. Bride ------------------------------ GARY L. BRIDGE /s/ N. Dan Reeve ------------------------------ N. DAN REEVE

Dates Referenced Herein

Referenced-On Page
This ‘SC 13G/A’ Filing    Date First  Last      Other Filings
Filed on:2/17/9814None on these Dates
 List all Filings 
Top
Filing Submission 0000901309-98-000016   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 5:41:32.2pm ET